
Beef Research News
Brought to you by Kansas State University
College of Veterinary Medicine - Farm Animal Section
August 2006
Contents:
New animal
drugs for use in animal feeds; Melengestrol, Lasalocid, and Tylosin
Federal Register: July 12, 2006 (Volume 71, Number 133)
Department of Health and Human Services
Food and Drug Administration
http://a257.g.akamaitech.net/7/257/2422/01jan20061800/edocket.access.gpo.gov/2006/E6-10878.htm
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of an abbreviated new animal drug
application (ANADA) filed by Ivy Laboratories, Div. of Ivy Animal
Health, Inc. The ANADA provides for use of single-ingredient Type A
medicated articles containing melengestrol, lasalocid, and tylosin to
make three-way combination drug Type C medicated feeds for heifers fed
in confinement for slaughter.
DATES: This rule is effective July 12, 2006.
FOR FURTHER INFORMATION CONTACT: Daniel A. Benz, Center for Veterinary
Medicine (HFV-104), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-0223, e-mail: daniel.benz@fda.hhs.gov.
Heat Stress in Feedlots
Summer temperatures have been soaring and cattle on feed have felt the
effects. Minimizing the negative impacts of heat on cattle is a
challenge for many feedlot producers. Heat stress reduces performance by
limiting intake and can also lead to death in severe conditions. High
ambient temperature, relative humidity, sunlight, and very little wind
combine to increase animal heat load. Management strategies for managing
thermal stress include providing shades, adequate clean water sources
and sprinkling the animals and the environment. Wetting the animals
allows them to cool through evaporation of the water. It is important to
soak the animals rather than mist them as misting increases the humidity
in the environment and can create an insulation layer. It is also
important to be sure there is ample room for all animals to drink as
needed; supplemental water tanks in the pen may be helpful during
prolonged periods of heat. Several articles listed below evaluated the
aspects of heat management in the feedyard.
T. L. Mader, M. S. Davis, and T. Brown-Brandl.
Environmental factors
influencing heat stress in feedlot cattle J Anim Sci 2006 84: 712-719.
T. L. Mader and M. S. Davis.
Effect of management strategies on reducing
heat stress of feedlot cattle: Feed and water intake J Anim Sci 2004 82:
3077-3087.
F. M. Mitlöhner, M. L. Galyean, and J. J. McGlone.
Shade effects on
performance, carcass traits, physiology, and behavior of heat-stressed
feedlot heifers J Anim Sci 2002 80: 2043-2050.
F. M. Mitlohner, J. L. Morrow, J. W. Dailey, S. C. Wilson, M. L. Galyean,
M. F. Miller, and J. J. McGlone.
Shade and water misting effects on
behavior, physiology, performance, and carcass traits of heat-stressed
feedlot cattle J Anim Sci 2001 79: 2327-2335.
Research Evaluates
BRD in Feedlot
Recent research reported in the Journal of Animal Science characterized
the genetic, environmental, and economic factors related to incidence of
bovine respiratory disease (BRD) in feedlot calves. Records from 18,112
calves representing 9 breeds and 3 composites over a 15 year period were
evaluated. BRD incidence ranged from 5-44% through the years. The
epidemiological pattern indicated that BRD infection increased
dramatically after 5 d on feed. BRD infection in the feeding phase was
not influenced by previous BRD infection prior to sending to the
feedlot. Evaluation of BRD incidence rates between breeds revealed few
significant breed differences. Purebred and composite breed types had
similar susceptibility to BRD. Heritability for resistance to BRD ranged
from 0.04 to 0.08 ± 0.01. When the observed heritability was transformed
to an underlying continuous scale, the estimate increased to 0.18. The
authors theorized that selection for BRD resistance could occur, yet and
phenotypes for BRD resistant animals must be identified. The study also
estimated the economic losses associated with lower gains and treatment
costs for BRD infection in a 1,000 head feedlot to be $13.90 per animal.
This figure did not include labor and handling costs for treating the
sick animals.
G. D. Snowder, L. D. Van Vleck, L. V. Cundiff, and G. L. Bennett.
Bovine
respiratory disease in feedlot cattle: Environmental, genetic, and
economic factors J Anim Sci 2006 84: 1999-2008.
KSU-CVM Farm Animal Expands Faculty
Dr. Meredyth Jones joined the Farm Animal section in the
Kansas State University College of Veterinary Medicine. Dr. Jones will
be board certified in food animal internal medicine and will be working
in the field services section. After completing her doctor of veterinary
medicine, Dr. Jones entered private practice in a Kentucky mixed animal
practice. She later returned to Oklahoma State University where she
completed a residency in food animal medicine and surgery. Dr. Jones
research interests are small ruminant urolithiasis and nutritional
support for critically ill animals.
2005 Beef Quality Audit
From Cattlenetwork.com:
http://www.cattlenetwork.com/content.asp?contentid=51398
RENO, Nev. (July 11, 2006) – Initial results from National Beef Audit
2005, funded in part by checkoff investments in the Beef Quality
Assurance Program, are in and offer U.S. cattlemen insight into beef
quality successes and future challenges over which they have some or all
control.
Identified in the new audit as the top three quality successes since the
2000 audit were: (1) improved microbiological safety; (2) improved
cattle genetics and beef of higher quality; and (3) fewer injection-site
lesions. The rankings are from interviews with beef end-users, including
exporters, purveyors, foodservice and retail channels.
Of note to producers, as more foreign markets reopen to U.S. beef, was
the response from beef exporters on the question, “What one quality
attribute could U.S. cattlemen change to make it easier for you to
export beef products?.” Exporters’ response: “source and age
verification,” followed by “more marbling.”
Asked to cite “the gold standard” for high-quality beef in foreign
markets, exporters ranked U.S. Prime No. 1, followed by U.S. Choice. As
for the perception foreign buyers have about U.S. beef flavor and
tenderness, 100 percent of those surveyed rated tenderness as “very
good.” Seventy percent rated the flavor of U.S. beef as “excellent,”
while 30 percent gave the rating of “very good.”
As for new opportunities in the “natural” market, respondents predicted
just over a 14 percent increase in domestic consumer demand for
“natural” beef products in the next 10 years, while international demand
is expected to grow by just over 10 percent.
“Lack of uniformity/consistency in quality” was ranked by end-users as
the No. 1 defect in the U.S. beef industry. That lack was further
defined by four things: (presence) of marbling; tenderness;
palatability; and inconsistency among and within quality grades.
Other defects identified included cuts being too large for
foodservice/restaurant trade; excess fat; abscesses/lesions in cuts,
trimmings and variety meats; blood splashed muscle; pathogens and food
safety; dark cutting muscle/lack of uniformity in size/shape/weight;
blood clots in cuts and trimmings; bruises; and lack of traceability to
meet export requirements.
The national audit was conducted by researchers and scientists from
Colorado State University (Fort Collins); Texas A&M University (College
Station); Oklahoma State University (Stillwater); and West Texas A&M
University (Canyon).
The study was conducted between July 2005 and June 2006. The work
included interviews with beef and beef product export decision-makers,
and with purveyors, restaurants, foodservice operators and supermarket
officials.
Specific quality data were collected at 16 U.S. packing plants. The
audit collected data for live cattle, carcasses/offal items on the
harvest floor and carcasses after chilling and after ribbing at the
12th/13th rib interface.
The beef audit is conducted every five years. It is part of the Beef
Quality Assurance Program, which was initiated by producers in 1982 and
is the nation’s oldest pre-harvest herd management education program.
Programs that certify trained producers in quality pre-harvest practices
are active in 47 states. Program materials are funded by the beef
checkoff.
BVD Vaccination in
Calves
A recent study reported in JAVMA showed that a single dose of an MLV
multivalent vaccine containing BVDV administered at 4 to 5 weeks of age
can stimulate a strong protective immune response in calves in the face
of high concentrations of maternal antibodies against BVDV. The
protective response in vaccinates was not associated with an increase in
serum antibody concentrations.
23 crossbred dairy calves were assigned to one of three treatment
groups:1 ) control – fed colostrum not containing antibodies to BVDV and
receiving sham vaccine,
2) colostral antibody-negative and vaccinated -
fed colostrum not containing antibodies to BVDV and receiving a
commercial BVDV (type 1 and 2) MLV vaccine, or
3) colostral
antibody-positive and vaccinated – fed colostrum containing antibodies
to BVDV and receiving a commercial BVDV (type 1 and 2) MLV vaccine. The
calves were vaccinated at approximately 5 weeks of age. The calves were
challenged with virulent type 2 BVDV 3.5 months after vaccination.
Control calves that were fed colostrum that did not contain antibodies
against BVDV and received a sham vaccine developed severe disease (4 of
7 calves died or were euthanized). Calves that were vaccinated with the
commercial vaccine (whether or not they received BVDV
antibody-containing colostrum) developed mild or no clinical signs of
disease. In addition, BVDV was isolated from 6 of 7 control calves
beginning on day 3 and continuing through day 13 after challenge. Virus
was not isolated from any calves in the other treatment groups.
Zimmerman AD, Boots RE, Valli JL, Chase CCL.
Evaluation of protection
against virulent bovine viral diarrhea virus type 2 in calves that had
maternal antibodies and were vaccinated with a modified-live vaccine. JAVMA 228(11):1757-1761, 2006.
BVD Heifer Vaccinations
In another study published in JAVMA, seronegative heifers vaccinated
with 1 dose of a MLV BVD vaccine containing both types 1 and 2 had fewer
PI calves than heifers vaccinated with either 1 or 2 doses of a MLV
vaccine with only type 1 BVD.
160 heifers seronegative to BVDV and that had never been vaccinated
against BVDV were used. Heifers were either given one of 4 treatments:
1) a placebo vaccine only (controls), 2) 1 dose of an MLV vaccine
containing type 1 BVDV, 3) 2 doses (120 days apart) of an MLV vaccine
containing type 1 BVDV, 4) 1 dose of an MLV vaccine containing both
types 1 and 2 BVDV. The heifers were bred naturally and then exposed
with a type 2 BDV field isolate (heterologous to vaccine strain) between
62 and 104 days of gestation by instillation of the challenge inocula
into the nostrils.
At parturition, virus isolation and immunhistochemical analyses of
ear-notch specimens were used to determine persistently infected (PI)
status. 18 of 19 calves from heifers in the control group were PI, 6 of
18 calves from heifers receiving 1 dose of type 1 BVDV, 7 of 19 claves
from heifers receiving 2 doses of type 1 BVDV, and 0 of 18 claves from
heifers that received 1 dose of the type 1 and 2 BVDV vaccine were PI.
Ficken MD, Ellsworth MA, Tucker CM, Cortese VS.
Effects of modified-live
bovine viral diarrhea virus vaccines containing either type 1 or types 1
and 2 BVDV on heifers and their offspring after challenge with
noncytopathic type 2 BVDV during gestation. JAVMA 228(10):1559-1564,
2006.
_____________________________________________________________________
Beef Research News is produced by the Farm Animal section at
Kansas State University. To modify your subscription to this service
please email Erin Thomas (
ethomas@vet.k-state.edu )
For more information please contact:
Brad White, DVM, MS
Beef Production Medicine
Q211 Mosier Hall
Manhattan, KS 66506
bwhite@vet.ksu.edu